Cranial Stabilization Devices Market Size

Cranial Stabilization Devices Market size is slated to expand substantially between 2024 and 2032 on account of the rapid shift towards minimally invasive neurosurgeries. As per Globaldata.com, in 2022, there were a total of 6,670 minimally invasive neurosurgery procedures conducted in India.

Minimally invasive spine surgeries are preferred for pediatric abnormalities and spinal trauma. Recent advancements in cranial fixation and craniomaxillofacial systems will positively boost the industry revenue with the incorporation of advanced surgical tools and technologies. For instance, in June 2022, Medtronic announced the 510(k) clearance from the U.S. Food & Drug Administration (FDA) and the Breakthrough Design designation for its first-of-its-kind LigaPASS™ 2.0 Ligament Augmentation System.

Cranial Stabilization Devices Market Trends

One notable trend is advancements in technology that leads to the development of innovative cranial stabilization systems with enhanced features such as improved fixation, adjustability, and compatibility with imaging modalities. Moreover, the growing prevalence of neurological disorders and traumatic brain injuries, associated with rising healthcare expenditure, will further stimulate the product demand. 

Cranial Stabilization Devices Market Analysis 

The brain retractor systems segment will record a notable demand surge through 2032 owing to their ability to ensure stability during neurosurgeries. The development of highly sophisticated retractors enables high-quality visualization of tissues. Meanwhile, skull clamps are poised to secure significant industry growth owing to their increasing use during delicate surgeries and craniotomy drilling.

Hospitals segment is projected to hold a notable share in the cranial stabilization devices industry by 2032, attributed to high patient preference toward these facilities for surgical procedures. Hefty investments in next-generation hospital infrastructures to address the growing burden of neurological diseases and road accidents will boost the adoption of cranial surgery devices across these settings. For instance, in January 2023, the Government of India, Ministry of State for Education, and the Ministry of External Affairs launched India’s first-ever 100% carbon-neutral hospital backed by an investment of more than USD 145 million from Ambica Medical Foundation & Research Center.

North America cranial stabilization devices market size is poised to expand rapidly over 2024-2032 driven by the introduction of favorable reimbursement policies and the surging cases of brain cancer. Estimates indicate that the prevalence of primary cancerous tumors of the spinal cord and brain in adults reached 24,810 in the U.S. in 2023. Meanwhile, more than 5,200 American children under the age of 20 years were diagnosed with a central nervous system (CNS) tumor in 2023.

Cranial Stabilization Devices Market Share

The competitive landscape of the cranial stabilization devices industry includes:

• Integra LifeSciences Holdings Corporation
• Zimmer Biomet
• Changzhou Huida Medical Equipment
• OsteoMed (Marmon Group)
• DePuy Synthes (Johnson & Johnson)
• Jintan Huida Medical Instrument Co. Ltd.
• Micromar
• Pro med instruments
• ZheJiang Apeloa JiaYuan Pharmaceutical
• Medtronic
• Stryker
• B. Braun Mesulgen AG.
  

Cranial Stabilization Devices Industry News

• In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, secured 510(k) clearances from the U.S. Food and Drug Administration (FDA) for the TriALTIS Spine System and for TriALTIS Navigation Enabled Instruments.